Search

Background: Chest pain from coronary heart disease (CHD) accounts for more than 8 million emergency department visits every year in the United States, emphasizing the need for cardiovascular (CV) interventions to help reduce this high number. Meditation--a state of contemplation, concentration, and reflection--has the potential to help decrease CV disease. Methods: This article reviews the available data regarding the effects of meditation on various aspects of CV health. Results: During the past few decades, multiple studies have demonstrated the beneficial effects of meditation on various CV risk factors. In addition to decreasing CV mortality, meditation has also been shown to improve conditions such as hypertension, type 2 diabetes mellitus, dyslipidemia, and high cortisol levels. Still unclear is how current medical therapies impact overall CHD in comparison to meditation techniques. Conclusion: Prospective trials are needed to study the effects of meditation on CV risk factors, to provide guidelines for daily meditation practice, and to determine the efficacy of meditation compared to current pharmacologic therapies. [ABSTRACT FROM AUTHOR]

The article presents abstracts related to clinical practice including "In Colorectal Cancer Screening, Multitarget Stool DNA Test Appears to Have Higher Sensitivity Than Fecal Immunochemical Test," "Hydroxychloroquine May Not Improve Symptoms of Primary Sjögren Syndrome in Adults," "Decrease Risk of Major Vascular Events in Patients With Vascular Disease."

Several abstracts related to medical study are presented on topics including risk of all-cause mortality and serious cardiac arrhythmia, treatment for chronic hepatitis C and Confusion Assessment Method (CAM).

The article presents abstracts on medical topics which include the effectiveness of walking to decrease cardiovascular events risk in glucose impaired tolerance patient, efficacy of pregabalin for restless legs syndrome, and the use of cognitive behavioral therapy to treat children's anxiety.

This article discusses about the techniques that will change in the clinical practice. The different practices to be changed are Gastroenterology, Gynecology, Pediatrics and Pulmonary Medicine. Colorectal cancer testing procedure will be a little higher and sensitive as The American Cancer Society and American Gastroenterology Association have tweaked the rules for both the stool sample and the DNA sample to be tested for diagnosing cancer.

The article presents abstracts on medical topics which include severity of psoriasis, percutaneous coronary intervention (PCI) and cardioverter defibrillators.

Objective: This study examined the feasibility of using a remote magnetic catheter navigation system (MNS) in concert with an EAM system to perform detailed left ventricular scar mapping and ablation in a porcine model of healed myocardial infarction. Background: Substrate-based catheter ablation of ventricular tachycardia (VT) involves detailed electroanatomical mapping (EAM) of the ventricles. While a safe and effective procedure, VT ablation is nonetheless uncommonly performed, due in part to the technical challenges related to ventricular mapping. Methods: Using a prototype EAM system (CARTO-RMT), seven chronically infarcted swine were mapped using either: (i) a standard manually manipulated catheter or (ii) a magnetic remotely manipulated (Niobe) catheter. A total of 191 ± 54 and 221 ± 64 points were acquired to map the chamber either manually or remotely, respectively. Results: Procedure times were longer remotely (94 ± 22 vs. 59 ± 19 minute, P = 0.004; and 27 ± 8 vs. 18 ± 3 sec/point, P = 0.04), but this became less apparent with increased operator experience. However, the fluoroscopy time was significantly shorter with remote mapping (56 ± 56 vs. 244 ± 67 sec/map, P = 0.03). The calculated scar size was comparable between the two methods (16.3 ± 4.9 vs. 16.4 ± 4.8 cm2, P = 0.37). Pathologic examination confirmed that the MNS was able to precisely deliver radiofrequency lesions to the scar borders. Using the MNS, the error to reach an evenly distributed set of endocardial targets was 6.6 ± 3.6 mm and 4.6 ± 2.0 mm, using transseptal and retrograde approaches, respectively. Conclusions: Ventricular mapping using this remote navigation paradigm is technically possible and requires minimal fluoroscopy exposure, potentially facilitating ventricular substrate mapping and ablation. [ABSTRACT FROM AUTHOR]

The article presents abstracts on medical topics which include cephalexin drug, guidelines issued by the American Heart Association for controlling blood pressure (BP) and disease progression.

An introduction is presented in which the editor discusses various reports within the issue on topics including the misconceptions and knowledge gaps for treating systolic heart failure, the side effects of diabetic drugs on cardiovascular, and the techniques in deep vein thrombosis treatment.